Descripción

Structural overview of the CB2 cannabinoid receptor, which is primarily expressed in immune cells and microglia. CB2 activation by phytocannabinoids may modulate neuroinflammation associated with epilepsy.

Figure 61

Diagram

Source Paper

Receptors and Channels Possibly Mediating the Effects of Phytocannabinoids on Seizures and Epilepsy.

Pharmaceuticals (Basel, Switzerland) (2020)

PMID: 32751761

DOI: 10.3390/ph13080174

Cite This Figure

![Figure 61: Structural overview of the CB2 cannabinoid receptor, which is primarily expressed in immune cells and microglia. CB2 activation by phytocannabinoids may modulate neuroinflammation associated with epilepsy.]()

> Source: Lara Senn et al. "Receptors and Channels Possibly Mediating the Effects of Phytocannabinoids on Se." *Pharmaceuticals (Basel, Switzerland)*, 2020. PMID: [32751761](https://pubmed.ncbi.nlm.nih.gov/32751761/)

<figure>
  <img src="" alt="Structural overview of the CB2 cannabinoid receptor, which is primarily expressed in immune cells and microglia. CB2 activation by phytocannabinoids may modulate neuroinflammation associated with epilepsy." />
  <figcaption>Figure 61. Structural overview of the CB2 cannabinoid receptor, which is primarily expressed in immune cells and microglia. CB2 activation by phytocannabinoids may modulate neuroinflammation associated with epilepsy.<br>  Source: Lara Senn et al. "Receptors and Channels Possibly Mediating the Effects of Phytocannabinoids on Se." <em>Pharmaceuticals (Basel, Switzerland)</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32751761/">32751761</a></figcaption>
</figure>

Evidencia relacionada

CBD para Insomnio

Calificación A · 103 estudios